Dr. Evripidis Gavathiotis is an Associate Professor in the Department of Biochemistry and the Department of Medicine at Albert Einstein College of Medicine. He is a faculty member of the Einstein’s Center of Experimental Therapeutics, the Albert Einstein Cancer Center, the Wilf Family Cardiovascular Research Institute, the Institute of Aging Research and the Gottesman Institute for Stem Cell Biology and Regenerative Medicine. Dr. Gavathiotis grew up in Athens, Greece and received his bachelor degree in Chemistry from the University of Crete in 1998. He received his Ph.D in Biological Chemistry from the University of Nottingham in 2002 studying the structural mechanism of DNA-binding anti-cancer drugs. He worked at De Novo Pharmaceuticals in the Drug Design and Discovery department applying in silico drug design and lead optimization approaches for several therapeutic targets. Dr. Gavathiotis pursued post-doctoral fellowships at the Rockefeller University studying the structural and molecular biology of apoptosis signaling and at the Dana-Farber Cancer Institute and Harvard Medical School, where he studied the BCL-2 family of proteins in apoptosis and cancer. In 2009, Dr. Gavathiotis was appointed Instructor in the Department of Pediatrics at Harvard Medical School and then joined the faculty of Einstein in 2011. Dr. Gavathiotis has received numerous honors and awards throughout his career including the NIH Pathway to Independence Award, the AHA Scientist Development Award and Scholar Awards from the Gabrielle’s Angel Foundation for Cancer Research, the Sidney Kimmel Foundation for Cancer Research and the Alexandrine and Alexander L. Sinsheimer Foundation.
